Immix Biopharma Inc. (IMMX)
undefined
undefined%
At close: undefined
2.14
5.42%
After-hours Dec 13, 2024, 07:49 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - -89.52M - - -
Cost of Revenue 5.47K 2.13K 2.47K 2.32K 1.08K
Gross Profit -5.47K -89.52M -2.47K -2.32K -1.08K
Operating Income -16.14M -8.22M -1.35M -453.85K -842.50K
Interest Income 572.01K 0.50 179.85 101.98 109.98
Pretax Income -15.57M -8.22M -24.38M -1.13M -952.26K
Net Income -15.43M -8.23M -24.38M -1.15M -972.81K
Selling & General & Admin 7.41M 4.02M 1.23M 205.70K 259.34K
Research & Development 8.74M 4.20M 126.53K 248.15K 583.16K
Other Expenses - - - 512.00 224.00
Operating Expenses 16.14M 8.22M 1.35M 453.85K 842.50K
Interest Expense - 497.00 179.85K 101.98K 109.98K
Selling & Marketing Expenses - - - - -
Cost & Expenses 16.14M 8.22M 1.35M 453.85K 842.50K
Income Tax 26.41K 10.27K 6.01K 17.55K 20.55K
Shares Outstanding (Basic) 17.34M 13.23M 13.23M 7.77M 3.38M
Shares Outstanding (Diluted) 17.34M 13.23M 13.23M 7.77M 3.38M
EPS (Basic) -0.89 -0.62 -1.84 -0.15 -0.29
EPS (Diluted) -0.89 -0.62 -1.84 -0.15 -0.29
EBITDA -16.14M -8.22M -1.35M -451.53K -841.20K
Depreciation & Amortization 5.47K 2.13K 2.47K 2.32K 1.08K